Anna Dopler

Anna Dopler

Auto-generated profile, based on publicly available information

Anna Dopler

Division of Oncogenomics, Netherlands Cancer Institute , 1066 CX Amsterdam

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 May 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
AGAnastasia Gangaev
Anastasia Gangaev
SKSteven L. C. Ketelaars
Steven L. C. Ketelaars
OIOlga I. Isaeva
Olga I. Isaeva
SPSanne Patiwael
Sanne Patiwael
ADAnna Dopler
Anna Dopler
PKPia Kvistborg
Pia Kvistborg
The COVID-19 pandemic caused by SARS-CoV-2 is a continuous challenge worldwide, and there is an urgent need to map the landscape of immunogenic and immunodominant epitopes recognized by CD8+ T cells. Here, we analyze samples from 31 patients with COVID-19 for CD8+ T cell recognition of 500 peptide-HLA class I complexes, restricted by 10 common HLA alleles. We identify 18 CD8+ T cell recognized SARS-CoV-2 epitopes, including an epitope with immunodominant features derived from ORF1ab and restricted by HLA-A*01:01. In-depth characterization of SARS-CoV-2-specific CD8+ T cell responses of patients with acute critical and severe disease reveals high expression of NKG2A, lack of cytokine production and a gene expression profile inhibiting T cell re-activation and migration while sustaining survival. SARS-CoV-2-specific CD8+ T cell responses are detectable up to 5 months after recovery from critical and severe disease, and these responses convert from dysfunctional effector to functional memory CD8+ T cells during convalescence.

9 July 2024 in NAR Cancer
Verified
Journal Article
Open access
PDF file
SRSofia Ramalho
Sofia Ramalho
ADAnna Dopler
Anna Dopler
WFWilliam James Faller
William James Faller
In the past few decades, our view of ribosomes has changed substantially. Rather than passive machines without significant variability, it is now acknowledged that they are heterogeneous, and have direct regulatory capacity. This ‘ribosome heterogeneity’ comes in many flavors, including in both the RNA and protein components of ribosomes, so there are many paths through which ribosome specialization could arise. It is easy to imagine that specialized ribosomes could have wide physiological roles, through the translation of specific mRNA populations, and there is now evidence for this in several contexts. Translation is highly dysregulated in cancer, needed to support oncogenic phenotypes and to overcome cellular stress. However, the role of ribosome specialization in this is not clear. In this review we focus on specialized ribosomes in cancer. Specifically, we assess the impact that post-translational modifications and differential ribosome incorporation of ribosomal proteins (RPs) have in this disease. We focus on studies that have shown a ribosome-mediated change in translation of specific mRNA populations, and hypothesize how such a process could be driving other phenotypes. We review the impact of RP-mediated heterogeneity in both intrinsic and extrinsic oncogenic processes, and consider how this knowledge could be leveraged to benefit patients.

20 October 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
ADAnna Dopler
Anna Dopler
FAFerhat Alkan
Ferhat Alkan
YMYuval Malka
Yuval Malka
KHKelly Hoefakker
Kelly Hoefakker
OIOlga I. Isaeva
Olga I. Isaeva
WFWilliam James Faller
William James Faller
Inflammatory cytokines are pivotal to immune responses. Upon cytokine exposure, cells enter an “alert-state” that enhances their visibility to the immune system. Here, we identified an “alert-state” subpopulation of ribosomes (ASRs) defined by the presence of the P-stalk. We show that ASRs are formed in response to cytokines linked to tumor immunity, and are involved in the preferential translation of mRNAs vital for the cytokine response. Mechanistically, ASRs are required for the efficient translation of transmembrane domains of receptor molecules involved in cytokine-mediated processes. Importantly, loss of the ASR prevents CD8+ T cell recognition and killing, and inhibitory cytokines like TGFβ hinder ASR formation, suggesting that the ASR is a central regulatory hub upon which multiple signals converge. Thus, the ASR is an essential mediator of the cellular rewiring that occurs following cytokine exposure, via the translational regulation of this process.

7 August 2025 in NAR Cancer
Verified
Journal Article
Open access
ADAnna Dopler
Anna Dopler
EKEdwin S Kyei-Baffour
Edwin S Kyei-Baffour
MKMandy Kerkhoff
Mandy Kerkhoff
FAFerhat Alkan
Ferhat Alkan
YMYuval Malka
Yuval Malka
WFWilliam J Faller
William J Faller
The presentation of peptides on HLA molecules is essential to CD8+ T cell responses. Here, we show that loss of uL14 significantly downregulates the expression of antigen processing and presentation (APP) components in melanoma cell lines. Peptides generated following knockdown show different characteristics, with altered peptide charge, and differences in anchor residue positions. These peptides also have lower predicted binding to the HLA alleles and a shorter predicted HLA-peptide complex half-life. These result in a functional difference in APP, and knockdown of uL14 causes a reduction in the ability of CD8+ T cells to recognize and kill melanoma cells in a co-culture assay. Together, our data suggest that loss of uL14 alters the peptide pool available for presentation and thus may act as an escape mechanism from tumor immune surveillance.